Jian-sheng Lu
20 Dongdajie Street
Beijing, 100071, China
Beijing, 100071, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Tetanus toxin and botulinum neurotoxin-derived fusion molecules are effective bivalent vaccines.
Journal: Applied microbiology and biotechnology
Published: July 25, 2023
Characterization of a novel tetravalent botulism antitoxin based on receptor-binding domain of BoNTs.
Journal: Applied microbiology and biotechnology
Published: January 26, 2023
Immunogenicity and immunoprotection of the functional TL-HN fragment derived from tetanus toxin.
Journal: Vaccine
Published: May 18, 2022
Development and evaluation of a tetravalent botulinum vaccine.
Journal: Human vaccines & immunotherapeutics
Published: April 18, 2022
Recombinant L-HN Fusion Antigen Derived from the L and HN Domains of Botulinum Neurotoxin B Stimulates a Protective Antibody Response Against Active Neurotoxin.
Journal: Neurotoxicity research
Published: October 31, 2020
Evaluation of a recombinant tetanus toxin subunit vaccine.
Journal: Toxicon : official journal of the International Society on Toxinology
Published: May 27, 2020
Development and evaluation of candidate subunit vaccine and novel antitoxin against botulinum neurotoxin serotype E.
Journal: Human vaccines & immunotherapeutics
Published: June 19, 2019
Development and evaluation of candidate subunit vaccine against botulinum neurotoxin serotype B.
Journal: Human vaccines & immunotherapeutics
Published: November 16, 2018
The highly pathogenic H5N1 influenza A virus down-regulated several cellular MicroRNAs which target viral genome.
Journal: Journal of cellular and molecular medicine
Published: October 17, 2016
Showing 1-12 of 12
Last Updated: 09/26/2026